These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 3592392)
1. Efficacy of Corynebacterium pseudotuberculosis bacterin for the immunologic protection of sheep against development of caseous lymphadenitis. LeaMaster BR; Shen DT; Gorham JR; Leathers CW; Wells HD Am J Vet Res; 1987 May; 48(5):869-72. PubMed ID: 3592392 [TBL] [Abstract][Full Text] [Related]
2. The incidence of caseous lymphadenitis in Alberta sheep and assessment of impact by vaccination with commercial and experimental vaccines. Stanford K; Brogden KA; McClelland LA; Kozub GC; Audibert F Can J Vet Res; 1998 Jan; 62(1):38-43. PubMed ID: 9442938 [TBL] [Abstract][Full Text] [Related]
3. [Development of an ELISA test to detect antibodies in vaccinated sheep or infected Corynebacterium pseudotuberculosis]. Solanet JJ; Malena R; Estein SM; Estevao Belchior S; Paolicchi FA Rev Argent Microbiol; 2011; 43(1):9-17. PubMed ID: 21491060 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of a commercially available vaccine against Corynebacterium pseudotuberculosis for use in sheep. Piontkowski MD; Shivvers DW J Am Vet Med Assoc; 1998 Jun; 212(11):1765-8. PubMed ID: 9621886 [TBL] [Abstract][Full Text] [Related]
5. Comparison of protection induced in lambs by Corynebacterium pseudotuberculosis whole cell and cell wall vaccines. Brogden KA; Cutlip RC; Lehmkuhl HD Am J Vet Res; 1984 Nov; 45(11):2393-5. PubMed ID: 6524735 [TBL] [Abstract][Full Text] [Related]
6. Acquired immunity after primary caseous lymphadenitis in sheep. Pépin M; Pardon P; Marly J; Lantier F; Arrigo JL Am J Vet Res; 1993 Jun; 54(6):873-7. PubMed ID: 8323055 [TBL] [Abstract][Full Text] [Related]
7. Protection in alpacas against Corynebacterium pseudotuberculosis using different bacterial components. Braga WU Vet Microbiol; 2007 Jan; 119(2-4):297-303. PubMed ID: 16982160 [TBL] [Abstract][Full Text] [Related]
8. Vaccination confers significant protection of sheep against infection with a virulent United Kingdom strain of Corynebacterium pseudotuberculosis. Fontaine MC; Baird G; Connor KM; Rudge K; Sales J; Donachie W Vaccine; 2006 Aug; 24(33-34):5986-96. PubMed ID: 16806606 [TBL] [Abstract][Full Text] [Related]
9. The effect of antibody to caseous lymphadenitis in ewes on the efficacy of vaccination in lambs. Paton MW; Mercy AR; Sutherland SS; Ellis TM; Duda SR Aust Vet J; 1991 Apr; 68(4):143-6. PubMed ID: 2069543 [TBL] [Abstract][Full Text] [Related]
10. Serological response of vaccinated sheep after challenge with Corynebacterium pseudotuberculosis. Sutherland SS; Ellis TM; Paton MJ; Mercy AR Aust Vet J; 1992 Jul; 69(7):168-9. PubMed ID: 1445082 [No Abstract] [Full Text] [Related]
11. Immunisation against ovine caseous lymphadenitis: comparison of Corynebacterium pseudotuberculosis vaccines with and without bacterial cells. Eggleton DG; Middleton HD; Doidge CV; Minty DW Aust Vet J; 1991 Oct; 68(10):317-9. PubMed ID: 1755781 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of an ovine caseous lymphadenitis vaccine formulated using a genetically inactive form of the Corynebacterium pseudotuberculosis phospholipase D. Hodgson AL; Carter K; Tachedjian M; Krywult J; Corner LA; McColl M; Cameron A Vaccine; 1999 Feb; 17(7-8):802-8. PubMed ID: 10067685 [TBL] [Abstract][Full Text] [Related]
13. Differential antibody responses to Corynebacterium pseudotuberculosis in sheep with naturally acquired caseous lymphadenitis. Ellis JA; Hawk DA; Holler LD; Mills KW; Pratt DL J Am Vet Med Assoc; 1990 May; 196(10):1609-13. PubMed ID: 2189849 [TBL] [Abstract][Full Text] [Related]
14. The control of Corynebacterium pseudotuberculosis infection in sheep flocks: a mathematical model of the impact of vaccination, serological testing, clinical examination and lancing of abscesses. O'Reilly KM; Medley GF; Green LE Prev Vet Med; 2010 Jun; 95(1-2):115-26. PubMed ID: 20304509 [TBL] [Abstract][Full Text] [Related]
15. Immunisation against ovine caseous lymphadenitis: correlation between Corynebacterium pseudotuberculosis toxoid content and protective efficacy in combined clostridial-corynebacterial vaccines. Eggleton DG; Haynes JA; Middleton HD; Cox JC Aust Vet J; 1991 Oct; 68(10):322-5. PubMed ID: 1755783 [TBL] [Abstract][Full Text] [Related]
16. A field trial to evaluate a whole cell vaccine for the prevention of caseous lymphadenitis in sheep and goat flocks. Menzies PI; Muckle CA; Brogden KA; Robinson L Can J Vet Res; 1991 Oct; 55(4):362-6. PubMed ID: 1790493 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the humoral and cellular immune response to different antigens of Corynebacterium pseudotuberculosis in Canindé goats and their potential protection against caseous lymphadenitis. Moura-Costa LF; Bahia RC; Carminati R; Vale VL; Paule BJ; Portela RW; Freire SM; Nascimento I; Schaer R; Barreto LM; Meyer R Vet Immunol Immunopathol; 2008 Nov; 126(1-2):131-41. PubMed ID: 18752855 [TBL] [Abstract][Full Text] [Related]
18. Use of a toxoid vaccine to protect goats against intradermal challenge exposure to Corynebacterium pseudotuberculosis. Brown CC; Olander HJ; Biberstein EL; Morse SM Am J Vet Res; 1986 May; 47(5):1116-9. PubMed ID: 3717735 [TBL] [Abstract][Full Text] [Related]
19. Immunisation against ovine caseous lymphadenitis: efficacy of monocomponent Corynebacterium pseudotuberculosis toxoid vaccine and combined clostridial-corynebacterial vaccines. Eggleton DG; Doidge CV; Middleton HD; Minty DW Aust Vet J; 1991 Oct; 68(10):320-1. PubMed ID: 1755782 [TBL] [Abstract][Full Text] [Related]
20. An improved Corynebacterium pseudotuberculosis vaccine for sheep. Cameron CM; Bester FJ Onderstepoort J Vet Res; 1984 Dec; 51(4):263-7. PubMed ID: 6533517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]